Dublin, Oct. 09, 2024 (GLOBE NEWSWIRE) — The “Proteomics Market by Instrumentation (Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray (Protein Chips), Reagents (Immunoassay), Services (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery) – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.
The global proteomics market is estimated to reach USD 60.5 billion by 2029 from USD 33.6 billion in 2024, at a CAGR of 12.4% during the forecast period of 2024 to 2029.
The market dynamics for proteomics reveal several key factors influencing its growth. Drivers include the growing demand for personalized medicines in clinical practices, high investments in pharmaceutical research and development (R&D), and rising applications in drug discovery and development. Additionally, increased private and government funding is supporting the expansion of the field.
However, the market faces restraints such as the high costs of proteomics instruments and technologies, as well as a lack of standardization. Opportunities exist in the form of advancements in bioinformatics, developments in single-cell proteomics research, and an increasing number of collaborations and strategic partnerships. Nonetheless, challenges such as the lack of data management and handling persist.
In 2023, North America accounted for the major share of the proteomics market. Asia-Pacific is likely to grow at significant CAGR during the forecast period owing to various factors such as growing fields of proteomics and genomics research in conjunction with an increase in funding toward research studies. Rising investment by biopharmaceutical companies, growing research activity in the area of mAb-based therapeutics are likely to drive market expansion in the region.
Research Coverage
This report provides a detailed picture of the proteomics market. It aims at estimating the size and future growth potential of the market across different segments such as technology, reagent, service, software, application, end-user, and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles, recent developments, and key market strategies.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 798 |
| Forecast Period | 2024-2029 |
| Estimated Market Value (USD) in 2024 | $33.6 Billion |
| Forecasted Market Value (USD) by 2029 | $60.5 Billion |
| Compound Annual Growth Rate | 12.4% |
| Regions Covered | Global |
Market Dynamics
- Drivers
- Growing Demand for Personalized Medicines in Clinical Practices
- High Investments in Pharmaceutical R&D
- Rising Applications in Drug Discovery and Development
- Increased Private and Government Funding
- Restraints
- High Costs of Proteomics Instruments and Technologies
- Lack of Standardization
- Opportunities
- Advancements in Bioinformatics
- Developments in Single-Cell Proteomics Research
- Increasing Number of Collaborations and Strategic Partnerships
- Challenges
- Lack of Data Management and Handling
Industry Analysis
- Trends/Disruptions Impacting Customer Business
- Technology Analysis
- Pricing Analysis
- Value Chain Analysis
- Supply Chain Analysis
- Ecosystem Analysis
- Patent Analysis
- Trade Analysis
- Key Conferences and Events, 2024-2025
- Regulatory Landscape
- Investment and Funding Scenario
- Key Stakeholders and Buying Criteria
- Impact of AI/Gen AI on Proteomics Market
List of Companies Profiled in the Report
- Thermo fisher Scientific Inc. (US)
- Agilent Technologies, Inc. (US)
- Merck KGaA (Germany)
- Danaher Corporation (US)
- Waters Corporation (US)
- Bio-Rad Laboratories, Inc. (US)
- Bruker Corporation (US)
- Revvity (US)
- Shimadzu Corporation (Japan)
- Illumina Inc. (US)
- Promega Corporation (US)
- Eurofins Scientific (Luxembourg)
- Qiagen (Netherlands)
- Charles River Laboratories (US)
- Protagene (Germany)
- Creative Proteomics (US)
- Horiba (Japan)
- Sengenics Corporation LLC (US)
- Labvantage-Biomax GmbH (Germany)
- Cell Signaling Technology, Inc. (US)
- FIOS Genomics (UK)
- Azenta Life Sciences (US)
- Medgenome (India)
- Biognosys AG (Switzerland)
- Macrogen Inc. (South Korea)
For more information about this report visit https://www.researchandmarkets.com/r/hcsx6f
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
